HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glenn Liu Selected Research

Prostate-Specific Antigen (Semenogelase)

12/2020Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial.
11/2020Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide.
12/2019Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.
1/2019Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
1/2018Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
4/2013Intermittent versus continuous androgen deprivation in prostate cancer.
6/2012Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): a trial of the Eastern Cooperative Oncology Group.
12/2009Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.
8/2008ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Glenn Liu Research Topics

Disease

61Prostatic Neoplasms (Prostate Cancer)
12/2023 - 09/2002
56Neoplasms (Cancer)
11/2022 - 03/2002
11Renal Cell Carcinoma (Grawitz Tumor)
12/2017 - 10/2011
9Neoplasm Metastasis (Metastasis)
01/2023 - 12/2004
8Disease Progression
12/2023 - 08/2003
4Fatigue
12/2023 - 12/2008
4Melanoma (Melanoma, Malignant)
01/2021 - 08/2008
4Neutropenia
10/2018 - 05/2008
4Hypertension (High Blood Pressure)
12/2016 - 05/2010
3Breast Neoplasms (Breast Cancer)
10/2017 - 01/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 09/2010
2Febrile Neutropenia
10/2018 - 04/2015
2Colorectal Neoplasms (Colorectal Cancer)
04/2016 - 01/2016
2Nausea
04/2016 - 12/2008
2Fever (Fevers)
04/2014 - 12/2008
2Anorexia
02/2009 - 12/2008
1Lymphopenia (Lymphocytopenia)
12/2023
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
12/2023
1Adenocarcinoma
12/2022
1Circulating Neoplastic Cells
11/2020
1Bradycardia
10/2018

Drug/Important Bio-Agent (IBA)

19AndrogensIBA
01/2023 - 08/2003
19Docetaxel (Taxotere)FDA Link
01/2023 - 04/2008
17Hormones (Hormone)IBA
01/2023 - 09/2002
9Prostate-Specific Antigen (Semenogelase)IBA
12/2020 - 08/2008
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 05/2010
7A-Form DNA (A-DNA)IBA
12/2023 - 12/2005
7VaccinesIBA
12/2023 - 12/2005
7Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2002
7Axitinib (AG 013736)IBA
01/2018 - 08/2005
6prostatic acid phosphataseIBA
12/2023 - 12/2005
5Sunitinib (Sutent)FDA Link
03/2017 - 09/2010
4pembrolizumabIBA
12/2023 - 01/2017
4Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 06/2003
4Prednisone (Sone)FDA LinkGeneric
01/2019 - 06/2011
4Tyrosine Kinase InhibitorsIBA
01/2019 - 12/2011
4taxaneIBA
06/2012 - 06/2011
4GemcitabineFDA Link
06/2012 - 06/2003
42-MethoxyestradiolIBA
04/2012 - 09/2005
3Androgen Receptors (Androgen Receptor)IBA
12/2022 - 02/2013
3Carboplatin (JM8)FDA LinkGeneric
11/2022 - 05/2008
3Interleukin-2 (IL2)IBA
01/2021 - 10/2011
3Angiogenesis InhibitorsIBA
01/2019 - 08/2005
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019 - 12/2011
3Bevacizumab (Avastin)FDA Link
03/2017 - 03/2014
3temsirolimusFDA Link
03/2017 - 03/2015
3gossypol acetic acidIBA
02/2016 - 05/2009
3Vitamin DFDA LinkGeneric
12/2015 - 09/2002
3ZD4054IBA
02/2015 - 08/2008
3Endothelin A ReceptorIBA
02/2011 - 12/2007
2DNA VaccinesIBA
12/2023 - 01/2019
2Taxoids (Taxanes)IBA
12/2022 - 01/2009
2FluoridesIBA
11/2020 - 12/2015
2ARQ 197IBA
10/2018 - 01/2017
2alovudineIBA
01/2018 - 12/2016
2Sodium Fluoride (Ossin)FDA Link
08/2017 - 01/2015
2VorinostatFDA Link
03/2017 - 12/2009
2Sorafenib (BAY 43-9006)FDA Link
03/2017 - 08/2008
2Proteins (Proteins, Gene)FDA Link
01/2017 - 06/2012
2Androgen Receptor AntagonistsIBA
12/2016 - 02/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2016 - 02/2016
2RamucirumabIBA
02/2016 - 09/2015
2Lapatinib (GW572016)FDA Link
01/2016 - 02/2013
2Mitoxantrone (Novantrone)FDA LinkGeneric
09/2015 - 06/2011
2Capecitabine (Xeloda)FDA Link
02/2015 - 06/2009
2pegfilgrastim (Neulasta)FDA Link
04/2014 - 06/2011
2Zoledronic Acid (Zometa)FDA Link
12/2013 - 10/2011
2CytokinesIBA
06/2013 - 10/2011
2Androgen Antagonists (Antiandrogens)IBA
04/2013 - 02/2011
2ixabepilone (BMS 247550)FDA Link
06/2012 - 06/2011
2Endothelin-1 (Endothelin 1)IBA
08/2008 - 12/2007
2Endothelins (Endothelin)IBA
08/2008 - 12/2007
2piritreximIBA
12/2005 - 06/2003
1NivolumabIBA
12/2023
1AmylasesFDA Link
12/2023
1Lipase (Acid Lipase)FDA Link
12/2023
1Histone DemethylasesIBA
12/2022
1ChromatinIBA
12/2022
1Lysine (L-Lysine)FDA Link
12/2022
1Transcription Factors (Transcription Factor)IBA
12/2022
1cabazitaxelFDA Link
12/2022
1Messenger RNA (mRNA)IBA
12/2022
1talazoparibIBA
11/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1ibrutinibIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Testosterone (Sustanon)FDA Link
12/2020
1enzalutamideIBA
11/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2019
1cediranib (AZD2171)IBA
01/2019
1Technetium Tc 99m MedronateIBA
01/2019
1Cancer VaccinesIBA
05/2018
1Immune Checkpoint InhibitorsIBA
05/2018

Therapy/Procedure

33Therapeutics
01/2023 - 03/2002
27Castration
12/2023 - 08/2008
13Drug Therapy (Chemotherapy)
01/2019 - 05/2008
2Immunotherapy
01/2019 - 12/2015
2Radiotherapy
01/2014 - 07/2012
1Intravenous Infusions
12/2023
1Cryosurgery
11/2018